Advertisement

Reactions Weekly

, Volume 1753, Issue 1, pp 261–261 | Cite as

Nivolumab

Type-1 diabetes mellitus: case report
Case report
  • 21 Downloads

Reference

  1. Venetsanaki V, et al. Diabetes mellitus secondary to treatment with immune checkpoint inhibitors. Current Oncology 26: e111-e114, No. 1, Feb 2019. Available from: URL: http://doi.org/10.3747/co.26.4151 - Greece

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations